OS Fund is a venture capital firm investing in U.S. biotechnology, life sciences, pharmaceuticals and AI-enabled drug discovery companies. It backs companies from Series A through later-stage venture rounds and has acted as a lead investor in a later-stage financing, making it most relevant for founders in life sciences and AI-driven therapeutics seeking venture capital.